Lamivudine plus darunavir boosted with ritonavir as simplification dual regimen in HIV-infected patients

INTRODUCTION: The combination of lamivudine plus a protease inhibitor boosted with ritonavir (PI/r) has become an alternative as simplification strategy in HIV-infected patients with toxicity/intolerance to other nucleoside analogues (NA). Lamivudine plus darunavir/r (DRV/r) could be an adequate onc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Int AIDS Soc
Autors principals: Luis Casado, Jose, Bañón, Sara, Moreno, Ana, Diaz de Santiago, Alberto, Gomez, Cristina, Perez-Elías, María J, Moreno, Santiago
Format: Artigo
Idioma:Inglês
Publicat: International AIDS Society 2014
Matèries:
Poster Sessions – Abstract P269
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4225277/
https://ncbi.nlm.nih.gov/pubmed/25397545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19801
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars